Rumored Buzz on aml system
Regardless of attaining a whole response with optimal induction therapy, nominal residual sickness usually persists, necessitating consolidation therapy to mitigate the risk of relapse by reducing residual disorder. In patients who may have acquired 7+3 induction therapy, consolidation therapy is initiated with significant-dose cytarabine, general